Life Stem Genetics Inc. (LIFS)
Life Stem Genetics Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in East Stroudsburg, PA, US. The stock last traded at $0.00, down 0.00% on the session, giving a market capitalisation of $4,584. On trailing twelve-month figures it carries a trailing P/E of -2.38, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Life Stem Genetics Inc. is most often compared with the following Healthcare names: